Accsys Technologies PLC
11 October 2007
11th October 2007
AIM: AXS
NYSE Euronext Amsterdam: AXS
This Replaces RNS Number: 5649F
Please note Directors name
Accsys Technologies plc ('Accsys Technologies' or 'the Company')
Directors Dealings
The Company announces that on 10th October 2007, Finlay Iain Morrison, Executive
Director of Accsys Technologies was granted options under the Company's
Unapproved Share Option Scheme to subscribe for a total of 1,000,000 ordinary
shares (the 'Options') of €0.01 at a price of €3.80 per share being the market
value of an ordinary share on the date of grant.
Subject to certain performance criteria being met, the Options will vest in
three separate and equal instalments starting not before October 2008.
For further information, please contact:
Accsys Technologies PLC William Paterson-Brown, +44 (0) 20 8114 2510
Executive Chairman
Collins Stewart Europe Tim Mickley / Michael O'Brien +44 (0) 20 7523 8000
Limited
Parkgreen Communications Justine Howarth / Bex +44 (0) 20 7851 7480
Saunders-Hewett
Citigate First Financial Jose Tijssen / Frank Jansen + 31 (0) 20 575 4024
B.V.
ENDS
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.